Martha J Ignaszewski
Dados Biográficos
| ID | 2938287 |
|---|---|
| NOME | Martha J Ignaszewski |
| PRENOMES | Martha J |
| SOBRENOME | Ignaszewski |
| ASSINATURA | IGNASZEWSKI M J |
| AFILIAÇÕES | BC Children's Hospital |
| ORCID | 0000-0003-4098-9805 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2024 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Re-making selves and social worlds
Across many settings in Canada and the US, overdose is now a leading cause of death among 10 to 18-year-olds. In the Canadian province of British Columbia (BC), there have been increased efforts to connect adolescents with substance use treatment, including live-in programs. While much previous work has focused on barriers to treatment among youth, less research has examined how adolescents, and in particular those experiencing high levels of res…
The stakes of stimulant use, psychosis, and antipsychotic treatment among youth who use drugs
Psychosis among youth who use drugs in the context of entrenched poverty is often addressed through aggressive forms of psychiatric intervention. Clinicians must carefully consider the benefits and drawbacks of this approach with this population because of how institutionalization and the sedating and numbing effects and affects of antipsychotics may be distinctly constraining. This study aims to increase understanding of the benefits, drawbacks,…
Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release
Buprenorphine is an effective treatment for opioid use disorder but can be slow when using a standard low-dose titration protocol to avoid precipitated withdrawal. This presents a substantial practical barrier in clinical practice. Recent low-dose induction strategies have attempted to simplify and shorten the process required for successful induction, including our own transdermal buprenorphine method, which achieves induction to sublingual bupr…
Sem obras proeminentes nesta página.
Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release
Buprenorphine is an effective treatment for opioid use disorder but can be slow when using a standard low-dose titration protocol to avoid precipitated withdrawal. This presents a substantial practical barrier in clinical practice. Recent low-dose induction strategies have attempted to simplify and shorten the process required for successful induction, including our own transdermal buprenorphine method, which achieves induction to sublingual bupr…
Re-making selves and social worlds
Across many settings in Canada and the US, overdose is now a leading cause of death among 10 to 18-year-olds. In the Canadian province of British Columbia (BC), there have been increased efforts to connect adolescents with substance use treatment, including live-in programs. While much previous work has focused on barriers to treatment among youth, less research has examined how adolescents, and in particular those experiencing high levels of res…
The stakes of stimulant use, psychosis, and antipsychotic treatment among youth who use drugs
Psychosis among youth who use drugs in the context of entrenched poverty is often addressed through aggressive forms of psychiatric intervention. Clinicians must carefully consider the benefits and drawbacks of this approach with this population because of how institutionalization and the sedating and numbing effects and affects of antipsychotics may be distinctly constraining. This study aims to increase understanding of the benefits, drawbacks,…
Anesthesia (1 obras) · Attention Deficit Hyperactivity Disorder (1 obras) · Buprenorphine (1 obras) · Child and Adolescent Psychosocial and Emotional Development (1 obras) · Clinical Psychology (1 obras) · Community Health and Development (1 obras) · Developmental psychology (1 obras) · Forensic Toxicology and Drug Analysis (1 obras) · Internal Medicine (1 obras) · Medicine (1 obras)